Rennova Health, Inc. (NASDAQ:RNVA) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
As previously announced, on August 22, 2018 the holders of a majority of the total voting power of the voting securities of Rennova Health, Inc. (the “Company”) approved by written consent an amendment (the “Amendment”) to the Company’s Certificate of Incorporation, as amended, to increase the number of authorized shares of common stock from 3,000,000,000 to 10,000,000,000 shares. The Company filed the Amendment with the Secretary of State of the State of Delaware on September 18, 2018.
A copy of the Amendment is filed as an exhibit to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Rennova Health, Inc. ExhibitEX-3.18 2 ex3-18.htm CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF RENNOVA HEALTH,…To view the full exhibit click here
About Rennova Health, Inc. (NASDAQ:RNVA)
Rennova Health, Inc. (Rennova), formerly CollabRx, Inc., is a provider of diagnostics and supportive software solutions to healthcare providers. The Company operates in three segments: clinical laboratory operations, supportive software solutions, and decision support and informatics operations. The Company is a healthcare enterprise that delivers products and services, including laboratory diagnostics, healthcare technology solutions, and revenue cycle management and intends to provide financial services, to medical providers. Rennova’s principal line of business is clinical laboratory blood and urine testing services. It is also engaged in the provision of urine drug toxicology testing to physicians, clinics and rehabilitation facilities in the United States. Its clinical laboratories include Biohealth Medical Laboratory, Inc.; Alethea Laboratories, Inc.; International Technologies, LLC; EPIC Reference Labs, Inc., and Epinex Diagnostics Laboratories, Inc.
